Predicted protein targets (top 20)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | ALDH1A1 | P00352 | 8/20 | 0.68 |
| ▸ | KMT2A | Q03164 | 7/20 | 0.68 |
| ▸ | MAPT | P10636 | 7/20 | 0.68 |
| ▸ | MEN1 | O00255 | 6/20 | 0.68 |
| ▸ | KDM4E | B2RXH2 | 5/20 | 0.68 |
| ▸ | POLB | P06746 | 3/20 | 0.68 |
| ▸ | LMNA | P02545 | 3/20 | 0.68 |
| ▸ | NPSR1 | Q6W5P4 | 2/20 | 0.68 |
| ▸ | EGFR | P00533 | 2/20 | 0.62 |
| ▸ | TDP1 | Q9NUW8 | 3/20 | 0.60 |
| ▸ | THRB | P10828 | 1/20 | 0.59 |
| ▸ | CISD1 | Q9NZ45 | 1/20 | 0.59 |
| ▸ | L3MBTL1 | Q9Y468 | 3/20 | 0.54 |
| ▸ | APEX1 | P27695 | 2/20 | 0.54 |
| ▸ | HTT | P42858 | 1/20 | 0.54 |
| ▸ | RECQL | P46063 | 1/20 | 0.54 |
| ▸ | GLA | P06280 | 1/20 | 0.53 |
| ▸ | HPGD | P15428 | 3/20 | 0.52 |
| ▸ | TSHR | P16473 | 3/20 | 0.52 |
| ▸ | CYP1A2 | P05177 | 2/20 | 0.52 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL8588438 | 0.98 | ALDH1A1 (0.65) | ALDH1A1KMT2AMAPTMEN1KDM4E | |
| Benzoic Acid SCHEMBL28633844 | 0.85 | ALDH1A1 (0.53) | ALDH1A1KMT2AMAPTMEN1KDM4E | |
| SCHEMBL4910895 | 0.84 | MAPT (0.68) | ALDH1A1KMT2AMAPTMEN1KDM4E | |
| SCHEMBL17466932 | 0.82 | MAPT (1.00) | ALDH1A1KMT2AMAPTMEN1KDM4E | |
| SCHEMBL8826952 | 0.82 | ESR1 (0.67) | ALDH1A1KMT2AMAPTMEN1KDM4E | |
| SCHEMBL5570254 | 0.82 | MAPT (0.65) | ALDH1A1KMT2AMAPTMEN1KDM4E | |
| SCHEMBL8826946 | 0.82 | ESR1 (0.67) | ALDH1A1KMT2AMAPTMEN1KDM4E | |
| SCHEMBL2965017 | 0.81 | ALDH1A1 (0.59) | ALDH1A1KMT2AKDM4EPOLBLMNA | |
| SCHEMBL22691969 | 0.81 | EGFR (0.71) | ALDH1A1KDM4EEGFRTDP1CISD1 | |
| SCHEMBL22691968 | 0.81 | EGFR (0.71) | ALDH1A1KDM4EEGFRTDP1CISD1 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 49 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| CN-115494040-B | Paper-based microfluidic sensor array platform and preparation method and application thereof | 哈深迪(广东)生物科技有限公司 | 2025-05-06 | — | — | CN | claimed |
| CN-115494040-A | Paper-based micro-fluidic sensor array platform and preparation method and application thereof | 哈深迪(广东)生物科技有限公司 | 2022-12-20 | — | — | CN | claimed |
| CN-115494040-B | Paper-based microfluidic sensor array platform and preparation method and application thereof | 哈深迪(广东)生物科技有限公司 | 2025-05-06 | — | — | CN | disclosed |
| CN-118373803-A | Synthesis method and application of fluorescent probe for lipase detection | 广西大学 | 2024-07-23 | — | — | CN | disclosed |
| US-20240084308-A1 | FIBROTIC TREATMENT | MONASH UNIVERSITY (AU) | 2024-03-14 | — | — | US | disclosed |
| US-11834663-B2 | Fibrotic treatment | MONASH UNIVERSITY (AU) | 2023-12-05 | — | — | US | disclosed |
| US-11834663-B2 | Fibrotic treatment | MONASH UNIVERSITY (AU) | 2023-12-05 | — | — | US | disclosed |
| US-11834663-B2 | Fibrotic treatment | MONASH UNIVERSITY (AU) | 2023-12-05 | — | — | US | disclosed |
| CN-115494040-A | Paper-based micro-fluidic sensor array platform and preparation method and application thereof | 哈深迪(广东)生物科技有限公司 | 2022-12-20 | — | — | CN | disclosed |
| EP-3553097-B1 | COPOLYMER AND OPTICAL FILM USING SAME | TOSOH CORP (JP) | 2022-05-04 | — | — | EP | disclosed |
| US-11306066-B2 | 4H-pyran compounds as insulin-regulated aminopeptidase (IRAP) inhibitors | MONASH UNIVERSITY (AU) | 2022-04-19 | — | — | US | disclosed |
| US-20180170891-A1 | 4H-Pyran Compounds as Insulin-Regulated Aminopeptidase (IRAP) Inhibitors | MONASH UNIVERSITY (AU) | 2018-06-21 | — | — | US | disclosed |
| EP-3328384-A1 | FIBROTIC TREATMENT | Monash University (AU) | 2018-06-06 | — | — | EP | disclosed |
| EP-3294721-A1 | 4H-PYRAN COMPOUNDS AS INSULIN-REGULATED AMINOPEPTIDASE (IRAP) INHIBITORS | Monash University (AU) | 2018-03-21 | — | — | EP | disclosed |
| WO-2017015720-A1 | FIBROTIC TREATMENT | MONASH UNIVERSITY (AU) | 2017-02-02 | — | — | WO | disclosed |
| WO-2017015720-A1 | FIBROTIC TREATMENT | MONASH UNIVERSITY (AU) | 2017-02-02 | — | — | WO | disclosed |
| WO-2016179645-A1 | 4H-PYRAN COMPOUNDS AS INSULIN-REGULATED AMINOPEPTIDASE (IRAP) INHIBITORS | MONASH UNIVERSITY (AU) | 2016-11-17 | — | — | WO | disclosed |
| WO-2016179645-A1 | 4H-PYRAN COMPOUNDS AS INSULIN-REGULATED AMINOPEPTIDASE (IRAP) INHIBITORS | MONASH UNIVERSITY (AU) | 2016-11-17 | — | — | WO | disclosed |
| US-20080107829-A1 | Cellulose compound, cellulose film, optical compensation sheet, polarizing plate, and liquid crystal display device | FUJIFILM CORPORATION (JP) | 2008-05-08 | — | — | US | disclosed |
| WO-1998043632-A1 | PROTEIN KINASE INHIBITOR | CALYX THERAPEUTICS, INC. (US) | 1998-10-08 | — | — | WO | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (4 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20180170891-A1 | 4H-Pyran Compounds as Insulin-Regulated Aminopeptidase (IRAP) Inhibitors | IAPP, ENPEP, DNPEP | ALDH1A1 2853/4885KMT2A 1612/4885MAPT 113/4885 |
| US-11306066-B2 | 4H-pyran compounds as insulin-regulated aminopeptidase (IRAP) inhibitors | IAPP, ENPEP, DNPEP | ALDH1A1 2853/4885KMT2A 1612/4885MAPT 113/4885 |
| US-11834663-B2 | Fibrotic treatment | MMP1, ENPEP, RNPEP | ALDH1A1 1883/4885KMT2A 2797/4885MAPT 3950/4885 |
| US-20240084308-A1 | FIBROTIC TREATMENT | MMP1, ENPEP, RNPEP | ALDH1A1 1883/4885KMT2A 2797/4885MAPT 3950/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.